INC424
Showing 1 - 25 of 519
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Trametinib
- +2 more
-
Miami, FloridaUniversity of Miami
Jun 27, 2022
Contraception Trial in Savannah (LPRI424 (dienogest/ethinylestradiol))
Active, not recruiting
- Contraception
- LPRI424 (dienogest/ethinylestradiol)
-
Savannah, GeorgiaFellows Research Alliance, Inc.
Sep 14, 2022
Parkinson Disease Trial in United States (CVN424 Low Dose, CVN424 High Dose, Placebo)
Completed
- Parkinson Disease
- CVN424 Low Dose
- +2 more
-
Long Beach, California
- +20 more
Aug 4, 2022
GVHD Trial in Worldwide (INC424)
Active, not recruiting
- Graft vs Host Disease
- INC424
-
Sao Paulo, Brazil
- +20 more
Oct 26, 2022
Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)
Enrolling by invitation
- Hypercholesterolemia
- Atherosclerotic Ischemic Disease
- lerodalcibep
- Inclisiran
-
Nantes, Cedex 01, France
- +6 more
Nov 3, 2022
Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide
Completed
- Idiopathic Myelofibrosis
- +2 more
-
Paris, France
- +9 more
Jun 22, 2021
Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)
Suspended
- Myelofibrosis
- Ruxolitinib
- +5 more
-
Adelaide, South Australia, Australia
- +37 more
Aug 18, 2022
Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)
Completed
- Primary Myelofibrosis
- +9 more
- LDE225
- INC424
-
Camperdown, New South Wales, Australia
- +17 more
Apr 3, 2020
Primary Myelofibrosis (MF), Post-Polycythemia Vera (PV) MF, Post-Essential Thrombocythemia (ET) MF Trial in Worldwide
Completed
- Primary Myelofibrosis (MF)
- +2 more
-
Beijing, Beijing, China
- +25 more
Aug 29, 2019
Polycythemia Vera Trial in Worldwide (Best Available Therapy, Ruxolitinib)
Completed
- Polycythemia Vera
- Best Available Therapy
- Ruxolitinib
-
Herston, Queensland, Australia
- +47 more
Jun 29, 2021
Cytokine Storm (Covid-19) Trial in Worldwide (Ruxolitinib, Placebo)
Glaucoma, Open-Angle Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser
Completed
- Glaucoma
- Open-Angle Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Dothan, Alabama
- +32 more
Feb 22, 2022
Leukemia Trial in Houston (Ruxolitinib)
Terminated
- Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 3, 2019
Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser
Active, not recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Dothan, Alabama
- +94 more
Nov 1, 2022
Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Pracinostat, Questionnaire)
Completed
- Myeloproliferative Diseases
- Ruxolitinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 10, 2019
Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)
Recruiting
- Alzheimer Disease
- +2 more
- JNJ-63733657
- Placebo
-
Birmingham, Alabama
- +143 more
Jan 31, 2023
Neurotrophic Keratitis Trial (BRM424 Ophthalmic Solution, Vehicle)
Not yet recruiting
- Neurotrophic Keratitis
- BRM424 Ophthalmic Solution
- Vehicle
- (no location specified)
Jun 28, 2023
Leukemia Trial in Houston (Ruxolitinib)
Completed
- Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 11, 2019